PPARGC1A and chronic obstructive pulmonary disease: Improved MMP and enhanced cytochrome c oxidase 1 and ATP are among the beneficial effects of SIRT1/PGC-1α/NRF/TFAM signaling activation, which protected against lung oxidative stress and inflammation in murine COPD [69].